HHS OIG Investigated Medicare Reimbursement, Medicaid Rebates

The HHS Office of Inspector General has looked into Medicare Part D prescription drug reimbursement, price substitutions in Part B and CMS communications of appropriate rebate amounts in Medicaid, OIG wrote in a summary of its reports published in the second half of 2018. Medicare Part D reimbursement increased, while utilization decreased Medicare Part D reimbursement for brand-name drugs increased 77 percent over a five-year period from 2011 to 2015, an OIG brief found. In that same time, utilization...